Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- oxytetracycline no separate page
Use: INDICATIONS AND USAGE Acute Infections Caused by Susceptible Strains of Pseudomonas aeruginosa. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per gram ophthalmic ointment: 5 mg/10,000 IU, 5 mg/10,000 units
- Per gram: 5 mg/10,000 IU
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Oxytetracycline + Polymyxin b as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
OXY-POLOxytetracycline (as hydrochloride) + Polymyxin B Sulfate | Ophthalmic Ointment 5 mg/ 10,000 IU per gramAluminum collapsible tube x 3.5g Box of 1’s | Rx | Egyptian International Pharmaceutical Industries Co. (EIPICO)Egypt | Ambica International Corporation | DRP-8217 | Jun 7, 2029 | |
TerramycinOxytetracycline Hydrochloride/Polymyxin B Sulfate | 5 mg/10,000 units per gram Ophthalmic OintmentAluminum tube x 3.5 g Box of 1’s | Rx | P.T. PfizerIndonesia | Importer: Pfizer, Inc. | DRP-2067 | Jul 9, 2029 | |
TetrapolOxytetracycline (as hydrochloride) + Polymyxin B Sulfate | 5 mg/10,000 IU per gram Ophthalmic OintmentAluminum collapsible tube x 3.5g Box of 1’s | Rx | Egyptian International Pharmaceutical Industries Co. (EIPICO)Egypt | Medilife Pharma, Inc. .Importer: Ambica International Corporation | DRP-8217-01 | Jun 7, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .